These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23295350)

  • 1. OPG/RANK/RANKL axis in stabilization of spontaneously restored sinus rhythm in permanent atrial fibrillation patients after mitral valve surgery.
    Xi L; Cao H; Zhu J; Røe OD; Li M; Wu Y; Wang D; Chen Y
    Cardiology; 2013; 124(1):18-24. PubMed ID: 23295350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative serum receptor activator of nuclear factor-κB ligand/osteoprotegerin predict stabilization of spontaneously restored sinus rhythm in persistent atrial fibrillation patients after mitral valve surgery.
    Cao H; Zhu J; Xi L; Røe OD; Chen Y; Wang D
    Cardiology; 2014; 127(3):183-9. PubMed ID: 24434592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoprotegerin/RANK/RANKL axis and atrial remodeling in mitral valvular patients with atrial fibrillation.
    Cao H; Li Q; Li M; Od R; Wu Z; Zhou Q; Cao B; Chen B; Chen Y; Wang D
    Int J Cardiol; 2013 Jul; 166(3):702-8. PubMed ID: 22178057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OPG/RANK/RANKL axis as a potential therapeutic target for atrial fibrillation.
    Tao H; Shi K; Yang JJ
    Cardiology; 2013; 125(3):173. PubMed ID: 23751957
    [No Abstract]   [Full Text] [Related]  

  • 5. OPG/RANK/RANKL axis in atrial fibrillation.
    Xi L; Cao H; Chen Y
    Cardiology; 2013; 125(3):174-5. PubMed ID: 23752030
    [No Abstract]   [Full Text] [Related]  

  • 6. Dysregulated atrial gene expression of osteoprotegerin/receptor activator of nuclear factor-κB (RANK)/RANK ligand axis in the development and progression of atrial fibrillation.
    Cao H; Wang J; Xi L; Røe OD; Chen Y; Wang D
    Circ J; 2011; 75(12):2781-8. PubMed ID: 22001292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heat shock proteins in stabilization of spontaneously restored sinus rhythm in permanent atrial fibrillation patients after mitral valve surgery.
    Cao H; Xue L; Xu X; Wu Y; Zhu J; Chen L; Chen D; Chen Y
    Cell Stress Chaperones; 2011 Sep; 16(5):517-28. PubMed ID: 21455828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative serum soluble receptor activator of nuclear factor-κB ligand and osteoprotegerin predict postoperative atrial fibrillation in patients undergoing cardiac valve surgery.
    Cao H; Zhou Q; Wu Y; Li Q; Røe OD; Chen Y; Wu Z; Wang D
    Ann Thorac Surg; 2013 Sep; 96(3):800-6. PubMed ID: 23870696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential profile of the OPG/RANKL/RANK-system in degenerative aortic native and bioprosthetic valves.
    Steinmetz M; Skowasch D; Wernert N; Welsch U; Preusse CJ; Welz A; Nickenig G; Bauriedel G
    J Heart Valve Dis; 2008 Mar; 17(2):187-93. PubMed ID: 18512489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The heart and the osteoclasts.
    Rosenheck S
    Cardiology; 2013; 124(1):51-2. PubMed ID: 23328209
    [No Abstract]   [Full Text] [Related]  

  • 11. Osteoprotegerin/RANK/RANKL axis in cardiac remodeling due to immuno-inflammatory myocardial disease.
    Liu W; Feng W; Wang F; Li W; Gao C; Zhou B; Ma M
    Exp Mol Pathol; 2008 Jun; 84(3):213-7. PubMed ID: 18417124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of receptor activator of nuclear factor kappa-B as a poor prognostic marker in breast cancer.
    Park HS; Lee A; Chae BJ; Bae JS; Song BJ; Jung SS
    J Surg Oncol; 2014 Dec; 110(7):807-12. PubMed ID: 25111682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression profile of receptor activator of nuclear-κB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer.
    Owen S; Ye L; Sanders AJ; Mason MD; Jiang WG
    Anticancer Res; 2013 Jan; 33(1):199-206. PubMed ID: 23267146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical expression of RANKL, RANK and OPG in gingival tissue of patients with periodontitis.
    Giannopoulou C; Martinelli-Klay CP; Lombardi T
    Acta Odontol Scand; 2012 Dec; 70(6):629-34. PubMed ID: 22214279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OPG, RANK and RANK ligand expression in thyroid lesions.
    Heymann MF; Riet A; Le Goff B; Battaglia S; Paineau J; Heymann D
    Regul Pept; 2008 Jun; 148(1-3):46-53. PubMed ID: 18367263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Osteoprotegerin mRNA/receptor activator of NF-kappaB ligand mRNA expressions in bone tissues of glucocorticoid-induced osteonecrosis of the femoral head].
    Wang J; Wang K; Shi Z; Zhang M
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Oct; 22(10):1161-4. PubMed ID: 18979868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The abundant synovial expression of the RANK/RANKL/Osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammation.
    Vandooren B; Cantaert T; Noordenbos T; Tak PP; Baeten D
    Arthritis Rheum; 2008 Mar; 58(3):718-29. PubMed ID: 18311801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation.
    Anné W; Willems R; Roskams T; Sergeant P; Herijgers P; Holemans P; Ector H; Heidbüchel H
    Cardiovasc Res; 2005 Sep; 67(4):655-66. PubMed ID: 15913581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The osteoprotegerin/RANK/RANKL system: a bone key to vascular disease.
    Kiechl S; Werner P; Knoflach M; Furtner M; Willeit J; Schett G
    Expert Rev Cardiovasc Ther; 2006 Nov; 4(6):801-11. PubMed ID: 17173497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The OPG/RANKL/RANK system and bone resorptive disease].
    Liu JZ; Ji ZL; Chen SM
    Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):655-60. PubMed ID: 15971575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.